Wyeth's Fen-Phen Settlement Approved

Drug maker Wyeth is expected to announce as early as today that a revised legal settlement, covering the most common damage claims for the diet drugs it once sold, has won final judicial approval.  About 5.8 million people took Wyeth’s drugs Redux or Pondimin before they were removed from the market in 1997. The drugs constituted the fenfluramine portion of the once popular fen-phen diet combination.